Literature DB >> 30392787

NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.

Qiaoting Deng1, Yan Geng2, Liying Zhao3, Ru Li4, Zhigao Zhang4, Kun Li4, Rongliang Liang5, Xiangyang Shao4, Maoliang Huang6, Daming Zuo7, Yingsong Wu8, Qiang Ma9.   

Abstract

Inflammation and immunity are important determinants of cancer initiation, promotion, and progression to cancer equilibrium or suppression. The NOD-like receptor family pyrin domain containing 3 (NLRP3) is an oligomeric intracellular immune receptor, and the main component of inflammasome. As a widely distributed effector of innate immunity, NLRP3 inflammasome affects development of many cancer types, but its exact role in colorectal cancer (CRC) is controversial. We found that cells with the macrophage (MΦ) marker CD68 and strong NLRP3 expression densely surrounded CRC tissue. The NLRP3 inflammasome was activated in MΦs by MΦ-CRC cell crosstalk; it resulted in faster migration of CRC cells, whereas blocking NLRP3 signaling suppressed CRC cell migration in vitro, and metastatic ability in vivo. NLRP3 signaling activation in MΦs can contribute to CRC cell migration and invasion.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Liver metastasis; Macrophage; NLRP3 inflammasome; Tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30392787     DOI: 10.1016/j.canlet.2018.10.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

Review 1.  Metastasis Organotropism: Redefining the Congenial Soil.

Authors:  Yang Gao; Igor Bado; Hai Wang; Weijie Zhang; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

Review 2.  The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies.

Authors:  Majid Ghanawat; Babak Arjmand; Fakher Rahim
Journal:  J Gastrointest Cancer       Date:  2022-01-24

3.  CircMERTK modulates the suppressive capacity of tumor-associated macrophage via targeting IL-10 in colorectal cancer.

Authors:  Mingchen Zhu; Zining Zhu; Pan Jiang; Junyu Zheng; Feng Yan; Jifeng Feng
Journal:  Hum Cell       Date:  2022-09-27       Impact factor: 4.374

Review 4.  The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target.

Authors:  Somayeh Vafaei; Hamed Taheri; Yasamin Hajimomeni; Amirhossein Fakhre Yaseri; Firoozeh Abolhasani Zadeh
Journal:  Clin Transl Oncol       Date:  2022-06-10       Impact factor: 3.340

Review 5.  The role of pyroptosis in modulating the tumor immune microenvironment.

Authors:  Jinxiang Wu; Lei Wang; Jianwei Xu
Journal:  Biomark Res       Date:  2022-06-23

6.  Nomograms based on lactate dehydrogenase to albumin ratio for predicting survival in colorectal cancer.

Authors:  Yugang Hu; Yanxiang Zhou; Yinghao Cao; Hao Wang; Yuanting Yang; Riyue Jiang; Qincheng Gong; Qing Zhou
Journal:  Int J Med Sci       Date:  2022-05-29       Impact factor: 3.642

7.  NLRP3 Inflammasome: A Potential Target in Isoflurane Pretreatment Alleviates Stroke-Induced Retinal Injury in Diabetes.

Authors:  Hong-Bin Lin; Ying-Hui Lin; Jin-Yu Zhang; Wen-Jing Guo; Andrea Ovcjak; Zhi-Jian You; Zhong-Ping Feng; Hong-Shuo Sun; Feng-Xian Li; Hong-Fei Zhang
Journal:  Front Cell Neurosci       Date:  2021-07-08       Impact factor: 5.505

Review 8.  Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.

Authors:  Sonia Missiroli; Mariasole Perrone; Caterina Boncompagni; Chiara Borghi; Alberto Campagnaro; Francesco Marchetti; Gabriele Anania; Pantaleo Greco; Francesco Fiorica; Paolo Pinton; Carlotta Giorgi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

9.  Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer.

Authors:  Letizia Mezzasoma; Vincenzo Nicola Talesa; Egidia Costanzi; Ilaria Bellezza
Journal:  Biomolecules       Date:  2021-05-25

Review 10.  Inflammasomes as therapeutic targets in human diseases.

Authors:  Yangxin Li; Hui Huang; Bin Liu; Yu Zhang; Xiangbin Pan; Xi-Yong Yu; Zhenya Shen; Yao-Hua Song
Journal:  Signal Transduct Target Ther       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.